TherapeuticsMD, Inc.
TXMD
$2.21
-$0.03-1.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.27M | 3.35M | 3.02M | 2.80M | 2.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.27M | 3.35M | 3.02M | 2.80M | 2.56M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.27M | 3.35M | 3.02M | 2.80M | 2.56M |
| SG&A Expenses | 4.64M | 4.76M | 5.01M | 4.12M | 4.45M |
| Depreciation & Amortization | 382.00K | 383.00K | 384.00K | 387.00K | 387.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.02M | 5.14M | 5.39M | 4.51M | 4.83M |
| Operating Income | -1.75M | -1.79M | -2.37M | -1.71M | -2.27M |
| Income Before Tax | -263.00K | 118.00K | -653.00K | 10.00K | -607.00K |
| Income Tax Expenses | 32.00K | 32.00K | 0.00 | -63.00K | -63.00K |
| Earnings from Continuing Operations | -0.30 | 0.09 | -0.65 | 0.07 | -0.54 |
| Earnings from Discontinued Operations | 78.00K | 93.00K | 84.00K | 229.00K | 85.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -217.00K | 179.00K | -569.00K | 302.00K | -459.00K |
| EBIT | -1.75M | -1.79M | -2.37M | -1.71M | -2.27M |
| EBITDA | -1.37M | -1.41M | -1.98M | -1.32M | -1.89M |
| EPS Basic | -0.02 | 0.02 | -0.05 | 0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | 0.01 | -0.03 | 0.01 | -0.03 |
| EPS Diluted | -0.03 | 0.01 | -0.06 | 0.02 | -0.05 |
| Normalized Diluted EPS | -0.01 | 0.01 | -0.03 | 0.01 | -0.03 |
| Average Basic Shares Outstanding | 46.30M | 46.30M | 46.28M | 46.23M | 46.19M |
| Average Diluted Shares Outstanding | 46.43M | 46.36M | 46.28M | 46.23M | 46.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |